Skip to main content
Clinical Trials/NCT05377476
NCT05377476
Completed
N/A

Investigation of the Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis

Hacettepe University1 site in 1 country48 target enrollmentJune 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Hacettepe University
Enrollment
48
Locations
1
Primary Endpoint
6 Min Walking Test
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

It was planned to examine the effects of motor imagery and action observation applied in addition to standard rehabilitation in people with multiple sclerosis on walking, fatigue, and trunk control.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
June 1, 2024
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Melike Sumeyye Ozen

Research Assistant

Bandırma Onyedi Eylül University

Eligibility Criteria

Inclusion Criteria

  • Being between the ages of 18-65
  • A definitive diagnosis of MS by a neurologist according to the 2017 McDonald Criteria
  • Expanded Disability Status Scale (EDSS) score of 4.0 and below (it is determined routinely by the physician during the examination)
  • Not having an attack in the last 3 months
  • A minimum score of 4 in each motor imagery ability (internal visual imagery, external visual imagery, and kinesthetic imagery) on the Movement Imagery Questionnaire-3 (MIQ-3)

Exclusion Criteria

  • cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score of less than 24
  • Having another musculoskeletal, cardiovascular, pulmonary, metabolic, or neurological disease severe enough to preclude participation in the study.
  • Having severe vision and hearing problems

Outcomes

Primary Outcomes

6 Min Walking Test

Time Frame: 6 week

It will be used to measure walking distance. Before the test is administered, individuals will be given the necessary information and will be asked to walk as fast as possible on a 30-meter track for 6 minutes.

Secondary Outcomes

  • Timed Up and Go Test(6 week)
  • Multiple Sclerosis Walking Scale-12(6 week)
  • RehaGait® (Hasomed, Magdeburg, Germany) Gait Analysis(6 week)
  • Fatigue Severity Scale(6 week)
  • Trunk Impairment Scale(6 week)

Study Sites (1)

Loading locations...

Similar Trials